References
- TandeAJPatelRProsthetic joint infectionClin Microbiol Rev201427230234524696437
- KurtzSOngKLauEMowatFHalpernMProjections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030J Bone Joint Surg Am200789478078517403800
- KurtzSMLauEWatsonHSchmierJKParviziJEconomic burden of periprosthetic joint infection in the United StatesJ Arthroplasty2012278 Suppl616522554729
- PeelTNDowseyMMBuisingKLLiewDChoongPFCost analysis of debridement and retention for management of prosthetic joint infectionClin Microbiol Infect201319218118622264335
- McConougheySJHowlinRGrangerJFBiofilms in periprosthetic orthopedic infectionsFuture Microbiol201498987100725302955
- GalloJKolarMNovotnyRRihakovaPTichaVPathogenesis of prosthesis-related infectionBiomed Pap Med Fac Univ Palacky Olomouc Czech Repub20031471273515034602
- RaoNZiranBHLipskyBATreating osteomyelitis: antibiotics and surgeryPlast Reconstr Surg2011127Suppl 1177S187S21200289
- FagottiLTatkaJSallesMJCQueirozMCRisk factors and treatment options for failure of a two-stage exchangeCurr Rev Musculoskelet Med2018420427
- VilchezFMartínez-PastorJCGarcía-RamiroSOutcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridementClin Microbiol Infect201117343944420412187
- ByrenIBejonPAtkinsBLOne hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcomeJ Antimicrob Chemother20096361264127119336454
- BryanAJAbdelMPSandersTLFitzgeraldSFHanssenADBerryDJIrrigation and debridement with component retention for acute infection after hip arthroplasty: improved results with contemporary managementJ Bone Joint Surg Am201799232011201829206791
- Lora-TamayoJMurilloOIribarrenJAA large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retentionClin Infect Dis201356218219422942204
- NodzoSRBoyleKKSpiroSNoconAAMillerAOWestrichGHSuccess rates, characteristics, and costs of articulating antibiotic spacers for total knee periprosthetic joint infectionKnee20172451175118128797875
- RicciardiBFMuthukrishnanGMastersENinomiyaMLeeCCSchwarzEMStaphylococcus aureus evasion of host immunity in the setting of prosthetic joint infection: biofilm and beyondCurr Rev Musculoskelet Med Epub201879
- GbejuadeHOLoveringAMWebbJCThe role of microbial biofilms in prosthetic joint infectionsActa Orthop201586214715825238433
- JonesMYingJHuttnerBRelationships between the importation, transmission, and nosocomial infections of methicillin-resistant Staphylococcus aureus: an observational study of 112 Veterans Affairs Medical CentersClin Infect Dis2014581323924092798
- KeynanYRubinsteinEStaphylococcus aureus bacteremia, risk factors, complications, and managementCrit Care Clin201329354756223830653
- FlemmingHCWingenderJThe biofilm matrixNat Rev Microbiol20108962363320676145
- HiramatsuKKatayamaYYuzawaHItoTMolecular genetics of methicillin-resistant Staphylococcus aureusInt J Med Microbiol20022922677412195737
- GrundmannHAires-de-SousaMBoyceJTiemersmaEEmergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threatLancet2006368953887488516950365
- DragoLDe VecchiENicolaLGismondoMRIn vitro evaluation of antibiotics’ combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infectionsBMC Infect Dis20077111117888153
- HankeMLHeimCEAngleASandersonSDKielianTCorrection: targeting macrophage activation for the prevention and treatment of Staphylococcus aureus biofilm infectionsJ Immunol20131901267096710
- GabrilovichDINagarajSMyeloid-derived suppressor cells as regulators of the immune systemNat Rev Immunol20099316217419197294
- PeranzoniEZilioSMarigoIMyeloid-derived suppressor cell heterogeneity and subset definitionCurr Opin Immunol201022223824420171075
- PengKTHsiehCCHuangTYStaphylococcus aureus biofilm elicits the expansion, activation and polarization of myeloid-derived suppressor cells in vivo and in vitroPLoS One2017128e018327128813499
- MiłobȩdzkaJKostaneckiSVLampeVZur Kenntnis des Curcumins. [Structure of curcumin]Berichte der Deutschen Chemischen Gesell-schaft191043221632170 German
- GeraMSharmaNGhoshMNanoformulations of curcumin: an emerging paradigm for improved remedial applicationOncotarget2017839666806669829029547
- YallapuMMJaggiMChauhanSCCurcumin nanoformulations: a future nanomedicine for cancerDrug Discov Today2012171–2718021959306
- Chainani-WuNSafety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa)J Altern Complement Med20039116116812676044
- LiBLiXLinHZhouYCurcumin as a promising antibacterial agent: effects on metabolism and biofilm formation in S. mutansBiomed Res Int201820183111
- JinCYLeeJDParkCChoiYHKimGYCurcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microgliaActa Pharmacol Sin200728101645165117883952
- YadavRJeeBAwasthiSKCurcumin suppresses the production of pro-inflammatory cytokine interleukin-18 in lipopolysaccharide stimulated murine macrophage-like cellsIndian J Clin Biochem201530110911225646051
- ShishodiaSMolecular mechanisms of curcumin action: gene expressionBiofactors2013391375522996381
- YenFLWuTHTzengCWLinLTLinCCCurcumin nanoparticles improve the physicochemical properties of curcumin and effectively enhance its antioxidant and antihepatoma activitiesJ Agric Food Chem201058127376738220486686
- de Abreu CostaLHenrique Fernandes OttoniMDos SantosMDimethyl sulfoxide (DMSO) decreases cell proliferation and TNF-α, IFN-γ, and IL-2 cytokines production in cultures of peripheral blood lymphocytesMolecules201722111789
- MaralSAlbayrakMPalaCYildizASahinOOzturkHBDimethyl sulfoxide-induced tonic-clonic seizure and cardiac arrest during infusion of autologous peripheral blood stem cellsCell Tissue Bank201819483183230099684
- MorrisCde WreedeLScholtenMShould the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxideTransfusion201454102514252224964911
- WindrumPMorrisTCDrakeMBNiederwieserDRuutuTSubcommitteeEEBMT Chronic Leukaemia Working Party Complications SubcommitteeVariation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centresBone Marrow Transplant200536760160316044141
- YenFLTsaiMHYangCMCurcumin nanoparticles ameliorate ICAM-1 expression in TNF-α-treated lung epithelial cells through p47 (phox) and MAPKs/AP-1 pathwaysPLoS One201385e6384523671702
- ThurlowLRHankeMLFritzTStaphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivoJ Immunol2011186116585659621525381
- SaqibUSarkarSSukKMohammadOBaigMSSavaiRPhytochemicals as modulators of M1-M2 macrophages in inflammationOncotarget2018925179371795029707159
- MantovaniASozzaniSLocatiMAllavenaPSicaAMacrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytesTrends Immunol2002231154955512401408
- BottnerFWegnerAWinkelmannWBeckerKErrenMGötzeCInterleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacementJ Bone Joint Surg Br2007891949917259424
- ShahiAParviziJThe role of biomarkers in the diagnosis of periprosthetic joint infectionEFORT Open Rev20161727527828461959
- MittalMSiddiquiMRTranKReddySPMalikABReactive oxygen species in inflammation and tissue injuryAntioxid Redox Signal20142071126116723991888
- GonzálezJFHahnMMGunnJSChronic biofilm-based infections: skewing of the immune responsePathog Dis2018763
- KerksiekKMPamerEGT cell responses to bacterial infectionCurr Opin Immunol199911440040510448135
- ZieglerCGoldmannOHobeikaEGeffersRPetersGMedinaEThe dynamics of T cells during persistent Staphylococcus aureus infection: from antigen-reactivity to in vivo anergyEMBO Mol Med201131165266621887823
- MedinaEHartlDMyeloid-derived suppressor cells in infection: a general overviewJ Innate Immun201817
- HeimCEVidlakDOdvodyJHartmanCWGarvinKLKielianTHuman prosthetic joint infections are associated with myeloid-derived suppressor cells (MDSCs): Implications for infection persistenceJ Orthop Res20183661605161329139571
- LewDPWaldvogelFAOsteomyelitisLancet2004364943136937915276398
- Dudek-WicherRKJunkaABartoszewiczMThe influence of antibiotics and dietary components on gut microbiotaPrz Gastroenterol2018132859230002765
- TamadahoRSEHoeraufALaylandLEImmunomodulatory effects of myeloid-derived suppressor cells in diseases: Role in cancer and infectionsImmunobiology20182234–543244229246400
- DorhoiADu PlessisNMonocytic myeloid-derived suppressor cells in chronic infectionsFront Immunol20178189529354120
- ZhouYZhangTWangXCurcumin modulates macrophage polarization through the inhibition of the Toll-like receptor 4 expression and its signaling pathwaysCell Physiol Biochem201536263164125998190
- GaoSZhouJLiuNCurcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-13J Mol Cell Cardiol20158513113925944087
- PastułaAMarcinkiewiczJMyeloid-derived suppressor cells: a double-edged sword?Int J Exp Pathol2011922737821314739
- CondamineTGabrilovichDIMolecular mechanisms regulating myeloid-derived suppressor cell differentiation and functionTrends Immunol2011321192521067974
- JiangMChenJZhangWInterleukin-6 trans-signaling pathway promotes immunosuppressive myeloid-derived suppressor cells via suppression of suppressor of cytokine signaling 3 in breast cancerFront Immunol20178184029326716
- ZambranoLMGBrandaoDARochaFRGLocal administration of curcumin-loaded nanoparticles effectively inhibits inflammation and bone resorption associated with experimental periodontal diseaseSci Rep201881665229703905